← Back to Search

Dietary Supplement

Solarplast Supplements for Muscle Injury

N/A
Recruiting
Research Sponsored by Kent State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Must not have
Subject has any chronic illness that causes continuous medical care
Subject has a history or presence of a clinically relevant cardiac, renal, hepatic, endocrine (including diabetes mellitus), pulmonary, biliary, gastrointestinal, pancreatic, or neurologic disorder
Timeline
Screening 3 weeks
Treatment Varies
Follow Up acute changes following exercise for 24 hours

Summary

This trial will investigate if taking Solarplast (R) supplements can help active adults recover better after intense exercise. Researchers want to find out if Solarplast (R) can reduce muscle damage,

Who is the study for?
This trial is for active adults who can handle high-intensity resistance exercise. Participants must be willing to take a daily supplement (Solarplast(R) or placebo) for 4 weeks and visit the lab weekly, plus attend three consecutive sessions after supplementation for training and tests.
What is being tested?
The study aims to find out if Solarplast(R), compared with a placebo, can reduce muscle damage and inflammation from intense workouts, as well as prevent performance decline. It involves taking supplements over four weeks followed by lab visits and testing.
What are the potential side effects?
Since the intervention includes a dietary supplement (Solarplast(R)) versus a placebo, specific side effects are not listed but could include typical reactions to new supplements such as digestive discomfort.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have a chronic illness that needs ongoing medical care.
Select...
I have a significant health condition affecting my heart, kidneys, liver, hormones (including diabetes), lungs, bile ducts, stomach, pancreas, or nervous system.
Select...
I have had cancer, other than non-melanoma skin cancer, in the last 2 years.
Select...
I am unable to perform physical exercise.
Select...
I am not taking any nutritional supplements or performance-enhancing drugs.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~acute changes following exercise for 24 hours
This trial's timeline: 3 weeks for screening, Varies for treatment, and acute changes following exercise for 24 hours for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Creatine Kinase Activity
Secondary study objectives
Mean Squat Velocity
Myoglobin Concentration
Peak Isometric Muscle Force
+2 more
Other study objectives
Cortisol Concentration
Glutathione (GSH) Activity
Interleukin 10 (IL-10) Concentration
+8 more

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: Solarplast (R)Active Control1 Intervention
100mg/day of Solarplast (R) supplementation (28 days).
Group II: PlaceboPlacebo Group1 Intervention
100mg/day of Placebo (maltodextrin (98.8%) and medium chain triglycerides (1.2%)).

Find a Location

Who is running the clinical trial?

Kent State UniversityLead Sponsor
43 Previous Clinical Trials
6,843 Total Patients Enrolled
~21 spots leftby Mar 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top